Metabolic-associated Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic-associated Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Effects of Meal Macronutrients on Postprandial Lipids [Phase 2]
Phase 2 clinical trial update by the National Institute of Diabetes and Digestive and Kidney Diseases evaluating how meal macronutrients inf…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease) [NA]
The clinical trial evaluating the effects of orange consumption on carbohydrate and lipid metabolism in metabolic associated fatty liver dis…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD [Phase 4]
A Phase 4 clinical trial is evaluating the effects of alogliptin combined with Actoplus Met on glucose and lipid metabolism and pancreatic f…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh
A clinical trial in rural Bangladesh is examining the prevalence of metabolic-associated fatty liver disease and its association with nutrit…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
A clinical trial is planned to screen for hyperuricemia in patients with metabolic-associated fatty liver disease (MAFLD); recruitment has n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD
A planned randomized trial at Assiut University compares essential phospholipids to a betaine HCl/L-glutamic acid combination for metabolic …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Efficacy and Safety of Rifaximin in Treating MAFLD [EARLY_Phase 1]
An early-phase Phase 1 clinical trial is evaluating the efficacy and safety of rifaximin for metabolic-associated fatty liver disease (MAFLD…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
A clinical trial comparing metabolic associated fatty liver disease and pancreatic steatosis in obese versus lean patients with chronic hepa…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Evaluation of Non-Invasive Tests for Metabolic Liver Disease
This clinical trial registry entry describes ongoing evaluation of non-invasive tests for metabolic liver disease, with recruitment currentl…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Benefits of Trimetazidine in MASLD Patients [Phase 2]
A Phase 2 trial evaluating trimetazidine in Metabolic Associated Fatty Liver Disease has completed.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial [Phase 2]
This clinical trial update reports a Phase 2 randomized study evaluating a combined herbal formulation (artichoke, milk thistle, turmeric, a…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver
Assiut University is studying whether glucose disposal rate can serve as a diagnostic metric for detecting metabolic associated fatty liver …
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Effect of CoQ10 on the Outcome of MAFLD Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of Coenzyme Q10 on outcomes in patients with metabolic-associated fatty liver disease/non-alcoh…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
This completed clinical trial evaluated the MAFLD fibrosis score's ability to detect fibrotic NASH in Egyptian patients with metabolic-assoc…
-
CLINICAL_TRIALS other · 2025-03-03Clinical Trial Update: Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study [Phase 4]
A Phase 4 pilot study is assessing the therapeutic response of an SGLT2 inhibitor in non-diabetic patients with Metabolic Associated Fatty L…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) [NA]
A clinical trial update focusing on characterizing and managing metabolic dysfunction-associated fatty liver disease (MAFLD) and its associa…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
A recruiting clinical study evaluating whether remnant cholesterol relates to the severity of metabolic-associated fatty liver disease (MAFL…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease [NA]
This clinical trial evaluates the effect of a vegetarian diet on patients with Metabolic Associated Fatty Liver Disease; the current status …
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) [Phase 2]
Phase 2 clinical trial investigating the potential benefits of itopride for metabolic-associated fatty liver disease (MAFLD).
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D [Phase 4]
Phase 4 trial investigating the effects of empagliflozin and dulaglutide on metabolic-associated fatty liver disease in patients with type 2…